CBP Officer’s Account of Jeffrey Epstein’s Solo Flight and Targeted Female PassengersStatute of Limitations Rules for Criminal Conspiracy, DOJ Tolling, and SEC Civil Actions
1 duplicate copy in the archive
Celgene exec Chris Hugin linked to $280 M settlement and political attacks over Revlimid price hikes
Title Matchkaggle-ho-028416
Case Filed-25976House OversightCelgene exec Chris Hugin linked to $280 M settlement and political attacks over Revlimid price hikes
November 11, 20252p5 persons
Case File
d-25976House OversightCelgene exec Chris Hugin linked to $280 M settlement and political attacks over Revlimid price hikes
Financial Record
The passage identifies a former Celgene executive (Chris Hugin) who was involved in aggressive marketing of Revlimid/Thalomid, a $280 M whistle‑blower settlement, and political targeting by a super‑PA Chris Hugin was a top executive at Celgene during the Revlimid/Thalomid controversy. Celgene paid $280 M to settle a whistle‑blower lawsuit alleging off‑label promotion. A super‑PAC funded by a Revli
Date
November 11, 2025
Source
House Oversight
Reference
House Oversight #028416
Pages
2
Persons
5
Integrity
No Hash Available
Loading document viewer...
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.
Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.